ArticleJournal of nanobiotechnology2026

Cholesterol-depleted macrophage membrane-coated nano-rapamycin for targeted atherosclerosis therapy.

Ruru Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.